Journal of Breast Cancer

Korean Breast Cancer Society (한국유방암학회)
권호 표지
DOI QR코드

DOI QR Code

Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy

  • Aghaee, Fahimeh (Department of Medical Physics, Tabriz University of Medical Sciences School of Medicine) ;
  • Islamian, Jalil Pirayesh (Department of Medical Physics, Tabriz University of Medical Sciences School of Medicine) ;
  • Baradaran, Behzaad (Department of Immunology, Tabriz University of Medical Sciences School of Medicine)
  • Published : 2012.06.30
⟨ Previous Next ⟩

Abstract

Breast cancer is the most common malignancy, and it is also the major cause of cancer-related deaths of women worldwide. Breast cancer treatment involves surgery, chemotherapy, radiation therapy, or combination therapy, and novel strategies are needed to boost the oncologic outcome. The non-metabolizable glucose analogue, 2-deoxy-D-glucose (2-DG) which inhibits glucose synthesis and adenosine triphosphate production, is one of the important discoveries involving the disturbances that can be caused to the process of the metabolism. The glucose analogue, 2-DG, is known as a tumor sensitizer to irradiation (IR) and chemotherapy, which help improve the treatment rates. It enhances the cytotoxicity via oxidative stress, which is more redundant in tumor cells than in normal ones. This article provides a brief summary on studies related to 2-DG chemo-/radio-sensitization effects by combination therapy of 2-DG/IR or 2-DG/doxorubicin.

Keywords

References

  1. Genetics of breast cancer for the practicing surgeon. Agashe PP, Shrikhande SV. http://www.bhj.org/journal/2001_4304_oct/review_537.htm. Accessed June 12th, 2011.
  2. Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Fenner M, et al. Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 2002;74:155-65. https://doi.org/10.1023/A:1016114026769
  3. Kaabinejadian S, Fouladdel SH, Ramezani M, Azizi E. p53 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry. J Biol Sci 2008; 8:380-5. https://doi.org/10.3923/jbs.2008.380.385
  4. de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993;341:1039-43. https://doi.org/10.1016/0140-6736(93)92407-K
  5. Han W, Kang SY; Korean Breast Cancer Society. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010;119:193-200. https://doi.org/10.1007/s10549-009-0388-z
  6. Rodeh HJ, Eisel D, Frost I. Apoptosis, Cell Death and Cell Proliferation. 3rd ed. Mannheim: Roche Diagnostics GmbH; 2000. p.2-6.
  7. Types of breast cancer: ER positive, HER2 positive, and triple negative. WebMD. http://www.webmd.com/breast-cancer/breast-cancer-typeser- positive-her2-positive. Accessed August 2nd, 2010.
  8. Breast cancer: tumor biology. Winship Cancer Institute. http://www. cancerquest.org/breast-cancer-molecular-biology. Accessed August 4th, 2010.
  9. Cobb JP, Hotchkiss RS, Karl IE, Buchman TG. Mechanisms of cell injury and death. Br J Anaesth 1996;77:3-10. https://doi.org/10.1093/bja/77.1.3
  10. Ghilotti M, Pierotti MA, Gariboldi M. Molecular markers for prediction of risk of radiation-related injury to normal tissue. J Nucleic Acids Investig 2010;1:55-61.
  11. Dwarkanath BS, Zolzer F, Chandana S, Bauch T, Adhikari JS, Muller WU, et al. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys 2001;50:1051-61. https://doi.org/10.1016/S0360-3016(01)01534-6
  12. Schwarz SB, Schaffer PM, Kulka U, Ertl-Wagner B, Hell R, Schaffer M. The effect of radio-adaptive doses on HT29 and GM637 cells. Radiat Oncol 2008;3:12. https://doi.org/10.1186/1748-717X-3-12
  13. Kunigal S, Lakka SS, Joseph P, Estes N, Rao JS. Matrix metalloproteinase- 9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors. Clin Cancer Res 2008; 14:3617-26. https://doi.org/10.1158/1078-0432.CCR-07-2060
  14. Gupta S, Farooque A, Adhikari JS, Singh S, Dwarakanath BS. Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy- D-glucose in animal tumors. J Cancer Res Ther 2009;5 Suppl 1:S16-20. https://doi.org/10.4103/0973-1482.55135
  15. Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, et al. Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 1996;35:103-11.
  16. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006;25:4633-46. https://doi.org/10.1038/sj.onc.1209597
  17. Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer 2002;87: 805-12. https://doi.org/10.1038/sj.bjc.6600547
  18. Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol 2004;53:116-22. https://doi.org/10.1007/s00280-003-0724-7
  19. Sinthupibulyakit C, Grimes KR, Domann FE, Xu Y, Fang F, Ittarat W, et al. p53 is an important factor for the radiosensitization effect of 2-deoxy- D-glucose. Int J Oncol 2009;35:609-15.
  20. Ahmad IM, Mustafa EH, Mustafa NH, Tahtamouni LH, Abdalla MY. 2DG enhances the susceptibility of breast cancer cells to doxorubicin. Cent Eur J Biol 2010;5:739-48.
  21. Zhang F, Aft RL. Chemosensitizing and cytotoxic effects of 2-deoxy-Dglucose on breast cancer cells. J Cancer Res Ther 2009;5 Suppl 1:S41-3.
  22. Kalia VK, Prabhakara S, Narayanan V. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy. J Cancer Res Ther 2009;5 Suppl 1:S57-60. https://doi.org/10.4103/0973-1482.55145
  23. Dwarakanath BS. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. J Cancer Res Ther 2009;5 Suppl 1:S27-31. https://doi.org/10.4103/0973-1482.55137
  24. Spitz DR, Sim JE, Ridnour LA, Galoforo SS, Lee YJ. Glucose deprivation- induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci 2000;899:349-62.
  25. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 2009; 418:29-37. https://doi.org/10.1042/BJ20081258
  26. Warburg O. On the origin of cancer cells. Science 1956;123:309-14. https://doi.org/10.1126/science.123.3191.309
  27. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR. 2-Deoxy- D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 2007; 67:3364-70. https://doi.org/10.1158/0008-5472.CAN-06-3717
  28. Jain VK, Kalia VK, Sharma R, Maharajan V, Menon M. Effects of 2-deoxy- D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int J Radiat Oncol Biol Phys 1985;11:943-50. https://doi.org/10.1016/0360-3016(85)90117-8
  29. Knowlton K, Mancini M, Creason S, Morales C, Hockenbery D, Anderson BO. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J Surg Res 1998;76:22-6. https://doi.org/10.1006/jsre.1998.5277
  30. Butt AJ, Firth SM, King MA, Baxter RC. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 2000;275:39174-81. https://doi.org/10.1074/jbc.M908888199
  31. Ahmad IM, Abdalla MY, Aykin-Burns N, Simons AL, Oberley LW, Domann FE, et al. 2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress. Free Radic Biol Med 2008;44:826-34. https://doi.org/10.1016/j.freeradbiomed.2007.11.007
  32. Singh G, Lakkis CL, Laucirica R, Epner DE. Regulation of prostate cancer cell division by glucose. J Cell Physiol 1999;180:431-8. https://doi.org/10.1002/(SICI)1097-4652(199909)180:3<431::AID-JCP14>3.0.CO;2-O
  33. Zhao Y, Liu H, Liu Z, Ding Y, LeDoux SP, Wilson GL, et al. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res 2011;71:4585-97. https://doi.org/10.1158/0008-5472.CAN-11-0127

Cited by

  1. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate vol.43, pp.5, 2012, https://doi.org/10.3892/ijo.2013.2080
  2. ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis vol.28, pp.17, 2014, https://doi.org/10.1101/gad.245910.114
  3. 2-Deoxyglucose Induces Cell Cycle Arrest and Apoptosisin Colorectal Cancer Cells Independent of Its Glycolysis Inhibition vol.67, pp.3, 2012, https://doi.org/10.1080/01635581.2015.1002626
  4. High Efficiency Apoptosis Induction in Breast Cancer Cell Lines by MLN4924/2DG Co-Treatment vol.16, pp.13, 2015, https://doi.org/10.7314/apjcp.2015.16.13.5471
  5. Nanoparticles Promise New Methods to Boost Oncology Outcomes in Breast Cancer vol.16, pp.5, 2012, https://doi.org/10.7314/apjcp.2015.16.5.1683
  6. Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication vol.6, pp.3, 2012, https://doi.org/10.4331/wjbc.v6.i3.148
  7. Combined Treatment with 2-Deoxy-D-Glucose and Doxorubicin Enhances the in Vitro Efficiency of Breast Cancer Radiotherapy vol.16, pp.18, 2012, https://doi.org/10.7314/apjcp.2015.16.18.8431
  8. Melatonin-Mediated Intracellular Insulin during 2-Deoxy- D -glucose Treatment Is Reduced through Autophagy and EDC3 Protein in Insulinoma INS-1E Cells vol.2016, pp.None, 2012, https://doi.org/10.1155/2016/2594703
  9. Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond? vol.3, pp.1, 2012, https://doi.org/10.2217/hep.15.36
  10. EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape vol.76, pp.5, 2016, https://doi.org/10.1158/0008-5472.can-15-2478
  11. Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro vol.6, pp.2, 2012, https://doi.org/10.15171/bi.2016.13
  12. 2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner vol.2017, pp.None, 2012, https://doi.org/10.1155/2017/2487297
  13. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway vol.15, pp.4, 2012, https://doi.org/10.3892/mmr.2017.6189
  14. Cancer metabolism: the volatile signature of glycolysis- in vitro model in lung cancer cells vol.11, pp.1, 2017, https://doi.org/10.1088/1752-7163/aa51d6
  15. Role of HDM2 Gene in Radio-Sensitivity of Esophageal Cancer Cell Lines to Irradiation vol.10, pp.6, 2012, https://doi.org/10.5812/ijcm.8950
  16. Streptozotocin-Induced Autophagy Reduces Intracellular Insulin in Insulinoma INS-1E Cells vol.37, pp.3, 2012, https://doi.org/10.1089/dna.2017.3874
  17. Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy vol.5, pp.1, 2018, https://doi.org/10.14338/ijpt-18-00023.1
  18. 2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation vol.6, pp.None, 2012, https://doi.org/10.3389/fmolb.2019.00090
  19. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met vol.9, pp.9, 2019, https://doi.org/10.3390/metabo9090188
  20. Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities vol.11, pp.None, 2012, https://doi.org/10.3389/fonc.2021.676562
  21. Noradrenaline‐induced l‐lactate production requires d‐glucose entry and transit through the glycogen shunt in single‐cultured rat astrocytes vol.99, pp.4, 2021, https://doi.org/10.1002/jnr.24783
  22. Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation vol.133, pp.21, 2021, https://doi.org/10.1007/s00508-021-01933-9